Target 2035 - update on the quest for a probe for every protein

Area of Science:

• Biochemistry
• Genomics
• Drug Discovery

Background:

• Despite advances in genomics, human proteome knowledge remains fragmented, hindering drug development.
• Proteins, not genes, drive biological functions in health and disease, necessitating a focus on proteomic understanding.
• Currently, ~35% of human proteins are uncharacterized, and less than 5% are drug targets, revealing a significant knowledge gap.

Discussion:

• The disconnect between genomic data and effective medicine development stems from incomplete proteomic characterization.
• Target 2035 addresses this gap by fostering international collaboration between public and private biomedical scientists.
• The initiative focuses on developing novel technologies for comprehensive proteome analysis and drug target identification.

Key Insights:

• Proteomic research is essential for translating genomic discoveries into therapeutic interventions.
• A substantial portion of the human proteome remains unexplored, representing a major bottleneck in drug discovery.
• Target 2035 aims to create chemogenomic and chemical/biological probes for the entire human proteome.

Outlook:

• By 2035, Target 2035 seeks to provide tools for understanding and targeting all human proteins.
• This initiative promises to accelerate the development of novel medicines by enabling comprehensive proteome-wide drug discovery.
• The project's success will bridge the gap between genetic information and effective therapeutic strategies.